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The definition of remodeling is “model again or differently, re-
construct.” In the airway, reaction to chronic inflammatory con-
ditions can lead to changes in the structural components of the 
airway wall, known as airway remodeling. Airway remodeling 
in response to allergens is a well-known key feature of patho-
genesis in asthma, a representative allergic disease of the lower 
airway.
1-3 The structural changes in airway remodeling comprise 
epithelial disruption, smooth muscle hypertrophy, goblet cell 
hyperplasia, subepithelial fibrosis, inflammatory cell infiltra-
tion, and vascular remodeling such as neovascularization.
4 The 
nasal and bronchial mucosa present similarities, and epidemi-
ologic studies have revealed that allergic rhinitis and asthma 
are closely related with each other.
5 Therefore, once regarded as 
two separate disease entities, they are now considered to be a 
common disease with different clinical manifestations. Thus, 
airway remodeling is presumed to occur in allergic rhinitis.
6 
Many previous studies have shown that airway remodeling ex-
ists in allergic rhinitis, although it seems to be less extensive 
than that in asthma.
7-11
Several studies have been performed to elucidate the epitheli-
al changes in the nasal mucosa of patients with allergic rhinitis. 
An electron microscopic study has revealed that damaged epi-
thelium and tight junctions of the epithelial cells were found in 
the nasal mucosa of patients with allergic rhinitis.
12 Allergic pa-
tients also present a marked goblet cell hyperplasia, and have a 
thicker epithelium than normal persons.
8,13 However, there was 
a contradictory result that patients with perennial rhinitis have 
an epithelium thickness comparable with that of normal per-
sons.
14 In addition, the epithelial damage is less extensive in the 
nose than in the bronchi of the same asthmatic patients.
15 Also, 
there is pseudo-thickening of the reticular basement membrane 
caused by collagen deposition in allergic rhinitis, although the 
extent was less severe than in asthma.
9 Furthermore, matrix 
metalloproteinases (MMPs), major proteolytic enzymes that 
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are involved in extracellular matrix turnover, is increased in the 
nasal mucosa 10 hours after nasal allergen challenge.
16 Expres-
sion of tissue inhibitors of matrix metalloproteinases (TIMPs) 
mRNA was also increased in the nasal mucosa of patients with 
perennial allergic rhinitis.
7
In terms of vascular remodeling, only few studies have been 
conducted to evaluate the association between angiogenesis 
and nasal airway remodeling until now. Mori et al.
17 have report-
ed that the hypervascularity and overexpression of the platelet-
derived endothelial cell growth factor, a potent angiogenic fac-
tor, were observed in the nasal mucosa of allergic rhinitis. How-
ever, the mechanism and exact process of remodeling, espe-
cially regarding angiogenesis, is still poorly understood in aller-
gic rhinitis.
In the present issue of Allergy, Asthma & Immunology Re-
search, Moon et al.
18 addressed this topic that angiogenic fac-
tors can be associated with nasal airway remodeling. The au-
thors assessed the role of representative angiogenic factors, in-
cluding vascular endothelial growth factor (VEGF) and platelet-
derived growth factor (PDGF), in the development of nasal air-
way remodeling in response to chronic allergic inflammation. 
Though the interpretation of the data is complicated, the results 
provide interesting information. After repetitive intranasal chal-
lenge with ovalbumin for 3 months in experimental mice, sig-
nificant nasal airway remodeling, such as increases in eosino-
phil infiltration, subepithelial fibrosis, goblet cell count, and 
MMP-9/TIMP-1 expression, was developed as compared with 
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control mice challenged with PBS. Of particularly interest, these 
abnormal responses were inhibited following systemic admin-
istration of SU1498, a VEGF receptor inhibitor, and/or AG1296, 
a PDGF receptor inhibitor. As far as we know, this is the first at-
tempt to clarify the association between inhibitors of potent an-
giogenic factors and nasal airway remodeling in allergic rhini-
tis, and the result is noteworthy.
This result provides indirect evidence that angiogenic factors 
may play some role in nasal airway remodeling. Increased eo-
sinophil infiltration was consistently inhibited by blocking the 
function of angiogenic factors in this study. It is well known that 
eosinophils are the main effector cells of allergic inflammation 
and an important source of VEGF along with other inflamma-
tory and structural cells in inflamed tissue.
19 Eosinophils are a 
source of several molecules, such as fibroblast growth factor-2, 
MMP-9, and TIMP-1 that are implicated in tissue remodeling 
processes.
20 In addition, PDGF is a physiologically important 
activator of eosinophils in pulmonary inflammation associated 
with asthma.
21 Furthermore, the authors found that subepithe-
lial fibrosis along with MMP-9/TIMP-1 expression were also in-
fluenced by the inhibitors of angiogenic factors. This is in accor-
dance of the previous report that there is a significant correla-
tion between VEGF and MMP-9 levels in asthmatic patients.
22 
Also, VEGF receptor inhibitors were effective in reducing MMP-
9 expression and reversing all pathophysiologic signs in an asth-
ma murine model. Therefore, Moon et al.
18 hypothesized that 
increased vascular permeability caused by angiogenic factors 
after chronic allergen challenges can lead to leakage of inflam-
matory cells, such as eosinophils. Subsequent augmented eo-
sinophilic inflammation may influence MMP-9/TIMP-1 and 
subepithelial fibrosis.
In the study, the authors only confirmed that inhibition of an-
giogenic factors can reduce the nasal airway remodeling. How-
ever, the authors did not provide an evidence of increased neo-
vascularization in the nasal mucosa. This may be a limitation of 
the study, and further studies are necessary to confirm the exact 
relationship between angiogenesis and nasal airway remodel-
ing.
Recently, scientific concern with regard to the nasal airway re-
modeling in allergic rhinitis has grown. Clarifying responsible 
mechanism for nasal airway remodeling is necessary in allergic 
rhinitis in order to better understand the underlying pathophys-
iology and develop new treatment strategy. In addition, eluci-
dating the role of angiogenic factors in nasal airway remodeling 
in the study may develop new treatment strategies in patients 
with allergic rhinitis in the future. In a clinical aspect, however, 
further studies regarding demonstrating dose-response rela-
tionship between anti-angiogenic agents and airway remodel-
ing and comparing treatment efficacy of airway remodeling 
among well-known anti-inflammatory drugs (steroid) and an-
ti-angiogenic agents are needed to investigate the clinical ap-
plicability of these anti-angiogenic agents.
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